Analystreport

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target lowered by analysts at Piper Sandler from $24.00 to $19.00.

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations